Mesoblast Limited vs Valero Energy Corporation — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while Valero Energy Corporation trades at $323.07 (market cap $93.27B). The key difference: Valero Energy Corporation is far larger — about 42.2× Mesoblast Limited's market cap, and Valero Energy Corporation pays a 1.48% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MESO | VLO | |
|---|---|---|
Market Cap | $2.21B | $93.27B |
Sector | Technology | Energy |
52-Week High | $20.96 | $323.92 |
52-Week Low | $12.88 | $133.38 |
Enterprise Value | $2.21B | $96.74B |
Dividend Yield | — | 1.48% |
Trailing returns across standard periods
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →